← Open Payments lookup

EBRAHIM HAZANY: Open Payments

NPI 1346359304 · NEWBURY PARK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,122 in 87 payments from 13 companies in 2025. Trend: 2023 $2,466 · 2024 $1,819 · 2025 $2,122

Food & beverage: $2,113Travel & lodging: $9
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.17$485
ABBVIE INC.15$405
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$252
Otsuka America Pharmaceutical, Inc.8$217
Alkermes, Inc.9$165
Axsome Therapeutics, Inc.9$163
Lundbeck LLC5$130
Bausch Health US, LLC5$115
Takeda Pharmaceuticals U.S.A., Inc.3$68
Tris Pharma Inc2$39

Products named: INGREZZA, VRAYLAR, REXULTI, CAPLYTA, ARISTADA, Auvelity, APLENZIN, TRINTELLIX.

Industry payments across CA — which companies pay providers there.